Total hip arthroplasty (THA) is the primary orthopaedic surgical procedure used to alleviate hip pain due to degenerative diseases and improve quality of life. However, early physical therapy following THA can be hindered by postoperative pain. Postoperative pain relief after joint surgery can be achieved with various modalities such as patient-controlled analgesia (PCA) with morphine, epidural analgesia (Epi), and lumbar plexus and/or sciatic blocks.[@B1],[@B2],[@B3],[@B4],[@B5] Each of these analgesic options has advantages and disadvantages. The advantages of PCA are fewer technical problems, and uniform and sustained analgesia with autonomy.[@B6],[@B7] The advantages of Epi are based on the associated improved postoperative analgesia, and a reduction in blood loss during surgery.[@B1] Although both PCA and continuous Epi provide sufficient pain relief, they are associated with multiple side effects, including arterial hypotension, respiratory depression, nausea/vomiting, and enuresis.[@B5] Continuous femoral nerve block (CFNB) after total knee arthroplasty (TKA) is one of the more popular types of analgesia with fewer side effects associated with the use of morphine or fentanyl.[@B1],[@B5] On the other hand, there are a few studies reporting on good outcomes using CFNB after THA.[@B2],[@B5],[@B8] The effects of CFNB on immediate postoperative outcome in patients undergoing THA have not been fully evaluated.

Deep venous thrombosis (DVT) is a common postoperative complication that can cause significant morbidity and mortality after orthopaedic surgery, especially THA and TKA.[@B9],[@B10] D-dimer is a degradation product of cross-linked fibrin; plasma levels increase after the cleavage of thrombi by activated plasmin and have been suggested to be a useful marker for the diagnosis of DVT.[@B11],[@B12] There are few reports comparing the influence of different postoperative analgesia techniques on patient outcomes, including D-dimer levels, after THA.

The aim of the present study was to compare pain relief with continuous Epi, PCA with morphine, and continuous three-in-one femoral nerve block on postoperative outcomes, including D-dimer levels, after THA.

METHODS
=======

We retrospectively reviewed and analyzed the clinical outcomes of three postoperative analgesia techniques after THA. We initially included110 patients (14 males and 96 females) who were admitted to Okayama Medical Center with hip pain and scheduled for THA under general anesthesia. Patients with any of the following criteria were excluded: local infection, cemented THA, revision THA, preoperative DVT, renal failure, bleeding tendency due to anticoagulant therapy, or allergy to local anesthetics or opioids. We obtained informed consent from patient before surgery and ethical approval was obtained from the Institutional Review Board. Ninety patients (14 males and 76 females; mean age, 68 years; range, 31 to 86 years) were included in this study. Preoperative comorbidity was analyzed according to the comorbidity index.[@B13]

All patients in this study had been operated on by the three experienced hip surgeons. The direct-lateral (modified Hardinge) approach was used in all patients. In this study, we used the cementless implants for THA (Summit, DePuy, Warsaw, IN, USA). Anesthesiologists instituted one of the following analgesic modalities: continuous Epi group (n = 30), PCA with morphine (PCA group, n = 30), or a CFNB group (n = 30) ([Table 1](#T1){ref-type="table"}). On postoperative day 1, all patients in the PCA and CFNB groups started fondaparinux (2.5 mg/day), which was continued for 14 days. In the Epi group, the first fondaparinux injection was administered 2 hours after removal of the epidural catheter on postoperative day 2. On postoperative day 1, all patients began a regimen of movement and strengthening exercises; they were encouraged to complete full weight-bearing exercises on postoperative day 2. On postoperative day 7, all patients underwent contrast-enhanced computed tomography (CT) to rule out DVT and/or pulmonary embolism (PE).

In the Epi group, Epi was administered before general anesthesia at the level of L2-3 or L3-4. An 18-gauge (G) catheter (Perifix, B-Brown, Tokyo, Japan) was threaded 4 to 5 cm into the epidural space. After a negative test, a dose of 0.2% ropivacaine (2 mg/mL) with 0.5 mg of fentanyl (4.5 × 10^-3^ mg/mL) was injected at a rate of 2-4 mL/hr postoperatively; epidural fentanyl was continued for 48 hours, and the epidural catheter was removed on postoperative day 2.

In the PCA group, each patient was educated about the use of PCA. All patients were provided with PCA devices supplying 1.0 mg/hr of morphine at a demand dose of 1.0 mg and a lockout interval of 20 minutes. The patients were encouraged to take a bolus as often as needed.

In the CFNB group, a continuous 3-in-1 block was administered following the induction of general anesthesia according to the method described by Winnie et al.[@B14] The femoral artery was located below the inguinal ligament, and an 18-G needle (1.3 × 50 mm, Contiplex, B-Braun) connected to a nerve stimulator (Stimuplex HNS12, B-Braun) was inserted just lateral to the artery *via* echography (MICROMAXX, SonoSite). The femoral nerve was accurately identified by eliciting contractions of the quadriceps with minimal stimulator settings (frequency, 2 Hz; current, 0.5 mA).[@B15] Using the Seldinger technique, a20-G catheter (0.85 × 1,000 mm, Contiplex, B-Braun) was placed 10-15 cm into the psoas compartment, secured in place with Steri-strips (3M Health Care, Tokyo, Japan), and covered with a transparent dressing (Tegaderm, 3M Health Care). After a negative aspiration test for blood, 0.2% ropivacaine (2 mg/mL) was injected at a rate of 4 mL/hr postoperatively.

Patients with intolerable pain were given loxoprofen sodium (60 mg) by mouth up to every 6 hours. If the pain persisted after 30 minutes, a diclofenac sodium suppository (25 mg) was administered. The patient\'s pain intensity at rest was self-assessed using a visual analog scale (VAS) at 24 hours postoperatively. The VAS for pain self-assessment is a widely used, valid, and reliable tool to measure pain intensity.[@B16] A 100-mm VAS was employed, and patients could rate pain intensity from no pain (0 mm) to unbearable pain (100 mm). Metoclopramide hydrochloride was used to treat nausea and vomiting. Clinical severity was assessed using the Harris hip score (HHS) on postoperative day 10.[@B17]

Food intake, use of supplemental analgesia, side effects, and the length of the hospital stay were recorded for each group. Peripheral blood samples were obtained from all patients preoperatively and on days 1, 3, and 7. All samples were analyzed within 1 hour of being obtained. The D-dimer level was determined at each time-point and used to assess coagulation and fibrinolytic factors.

Statistical Analysis
--------------------

All data were normally distributed and are expressed as means with standard deviation. Differences between groups were compared using a one-way analysis of variance (ANOVA) with the Bonferroni *post hoc* test. Fischer\'s exact test was used to compare differences in the gender ratio and the side effects between the three groups. All differences were considered statistically significant at a *p*-value \< 0.05.

A pilot study was carried out on ten patients in each group. As a result of the pilot study, the mean D-dimer levels (by postoperative day 7) were 6.5 g/mL in the Epi group, 6.6 g/mL in the PCA group, and 4.4 µg/mL in the CFNB group, with a standard deviation of 3. Based on the effect size in this pilot study, a power calculation for a trial (effect size, 0.34; α, 0.05; power, 0.8) suggest that 29 patients would be needed in each group.

RESULTS
=======

No significant differences were identified in the population data (race, age, gender ratio, body mass index, disease, and comorbidity index), preoperative HHS, operation time, or bleeding between the three groups ([Table 1](#T1){ref-type="table"}). The VAS score on postoperative day 1 did not significantly differ between the groups (*p* = 0.72) ([Fig. 1A](#F1){ref-type="fig"}). The amount of loxoprofen sodium hydrate and diclofenac sodium suppositories used by the CFNB group were significantly greater than that used by the PCA group (*p* \< 0.05) ([Fig. 1B](#F1){ref-type="fig"}).

Seven patients in the Epi group, eight in the PCA group, and one in the CFNB group developed nausea and/or vomiting after THA (*p* \< 0.05). Patients with nausea were unable to begin movement and strengthening exercises on postoperative day 1. An ANOVA test showed that there were significant differences in the mean amount of food intake on postoperative day 1 between the three groups (*p* \< 0.05). The amount of food intake on postoperative day 1 was significantly greater in the CFNB group (70% ± 32%) relative to the Epi (50% ± 41%, *p* \< 0.05) and PCA groups (37% ± 34%, *p* \< 0.01). Food consumption during breakfast and lunch was significantly greater in the CFNB group relative to the Epi group (*p* \< 0.05), whereas food consumption during all meals (breakfast, lunch, and dinner) was significantly greater in the CFNB group relative to the PCA group (*p* \< 0.01) ([Fig. 2](#F2){ref-type="fig"}). The mean hospital stay, including postoperative rehabilitation, was 25.3 ± 5.1, 23.3 ± 4.6, and 23 ± 3.1 days for the Epi, PCA, and CFNB groups, respectively; there was no significant difference in the length of the hospital stay between the three groups (*p* = 0.17).

There were no significant differences in D-dimer levels between the three groups, except for on day 7, when the mean D-dimer level was significantly lower in the CFNB group (4.5 ± 1.5 µg/mL) compared with the Epi (6.7 ± 4.0 µg/mL) and PCA (6.4 ± 4.0 µg/mL) groups (*p* \< 0.05) ([Fig. 3](#F3){ref-type="fig"}). On postoperative day 7, all patients underwent contrast-enhanced CT to rule out DVT and/or PE. DVT was identified by contrast-enhanced CT in two of 30 patients (6.7%) in both the Epi and PCA groups. No patients with DVT were identified in the CFNB group. There was not a significant difference in the incidence of DVT and/or PE as detected by contrast-enhanced CT (*p* = 0.54). There was no significant difference in the HHS on postoperative day 10 between the groups (*p* = 0.10).

DISCUSSION
==========

Postoperative pain control after THA enables patients to achieve earlier hip mobilization and restoration of function. Compared with PCA and continual Epi, CFNB provides good pain relief and is associated with fewer side effects such as nausea/vomiting, hematomas, arterial hypotension, and drowsiness.[@B2],[@B8] In our study, a significant number of patients in the Epi and PCA groups developed nausea and/or vomiting, which resulted in poor appetites and prevented these patients from starting postoperative rehabilitation on the day after surgery. We injected 0.2% ropivacaine (2 mg/mL) with 0.5 mg of fentanyl (4.5 × 10^-3^ mg/mL) in the Epi group. A high incidence of nausea/vomiting in the Epi and PCA groups might be influenced by the use of fentanyl or morphine. Different results might be obtained if studied without fentanyl in the Epi group. However, because a pure local anesthetic may provide dense sensory and motor blockade, a combination of an opioid and a local anesthetic is recommended.[@B6]

Postoperative analgesics promote early recovery with a lower incidence of DVT/PE.[@B18] Although no significant difference was found in the rate of DVT/PE between the three groups in this study, D-dimer levels were significantly higher in both the Epi and PCA groups compared with the CFNB group on postoperative day 7D-dimer is a protein fragment formed following the degradation of a fibrin clot; it is a useful indicator of several conditions, including venous thromboembolism, disseminated intravascular coagulation, and cardiovascular disease.[@B19] The higher D-dimer levels in the Epi and PCA groups in our study might have been affected by inadequate fluid and dietary intake due to postoperative nausea and vomiting. Delayed rehabilitation, including active exercise and walking, may have also contributed to the increase in D-dimer levels in these groups. Accordingly, the lower D-dimer levels in the CFNB group might have been influenced by early mobilization, rehabilitation, and a lower incidence of side effects.

However, it might not be valid to compare D-dimer levels of the Epi group with those of the PCA and CFNB groups, since patients in the Epi group did not receive chemical anticoagulation for 2 days in order to reduce the risk of bleeding. In patients receiving Epi, the risk of clinically significant bleeding increases in response to preventive measures against DVT/PE. According to the regional anesthesia and anticoagulation guidelines formulated by the American Society of Regional Anesthesia and Pain Medicine,[@B20] it is important to prevent epidural hematomas,[@B21] which is a potential disadvantage of this modality. To minimize the risk of hematomas, we cannot use fondaparinux or other anticoagulants in a patient under Epi. If it is necessary to remove an epidural catheter earlier than desired in order to use an antithrombotic agent, the use of nonsteroidal anti-inflammatory drugs can be increased. In general, CFNB may be a more advantageous technique in patients receiving anticoagulants.

A potential disadvantage of CFNB is a higher risk of falling. Because patients have an increased risk of falling as a consequence of persistent quadriceps muscle weakness after receiving high doses of this type of analgesia, both the density and flow of a CFNB should be controlled in accordance with its effect.[@B22] Although we did not use any knee immobilizers in this study, no patients in the CFNB group complained of postoperative quadriceps muscle weakness. In past studies, among patients receiving ropivacaine 0.2% at 8 mL/hr, 42% to 43% experienced quadriceps femoris weakness,[@B23] which may have resulted in an increase number of falls. Ilfeld et al.[@B24] recommended that if patients receiving ropivacaine 0.2% at 6 mL/hr experienced quadriceps femoris weakness, the basal administration rate should be reduced by half (to 3 mL/hr). Based on our experience, we consider a ropivacaine (0.2%) rate of 4 mL/hr to be appropriate in minimizing the risk of falling after THA. A variety of techniques, including continuous Epi, PCA, and CFNB have been used and compared in terms of their efficacy and postoperative rehabilitation outcomes in TKA patients.[@B5],[@B25] However, only a few reports have analyzed these three analgesic techniques in THA patients.[@B2],[@B8] In this study, we integrated the use of ultrasound-guided CFNB and compared it with the postoperative outcomes of these techniques after THA. There was no significant difference in the VAS score between the groups, and each group had good pain relief, which is in accordance with a previous report.[@B5] Although the amount of loxoprofen sodium hydrate administered in the PCA group was significantly lower than that administered in the CFNB group (*p* \< 0.05), this difference might be due to the ability of the PCA group to self-administer additional boluses of morphine. However, when large amounts of loxoprofen sodium hydrate are given, side effects may develop. Additionally, the frequent dosing of loxoprofen sodium hydrate increases the duties of the floor nurse.

Although CFNB enables selective anesthesia at the surgical site, the peripheral nerves have a complicated distribution and ectopia can make it more challenging. Although permanent neurological injury after regional anesthesia is rare in contemporary anesthetic practice, the rate of neurological complications after CFNB is higher than epidural anesthesia.[@B26] The use of supplemental devices enabled us to place the local nerve block with more precision in this study. We utilized echography, which is widely used owing to its portability and functionality. In the current study, there was no neurological injury after CFNB. The resulting enhanced echographic image quality and concurrent use of an electrostimulator enabled us to accurately identify the nerve and its innervation zone.

This study has some limitations and weakness. Firstly, the present study\'s retrospective nature is a weakness. A prospective, randomized, controlled study should be conducted to eliminate selection bias and obtain more consolidated results. Secondly, the sample size is relatively small, which makes explaining the effect of three different postoperative analgesia techniques difficult. To validate our findings, future studies with large sample sizes and a prospective design are needed to further define the efficacy of CFNB. Thirdly, we performed THA under general anesthesia in this study. However, some clinical studies support a transition to spinal conduction blockade for intraoperative anesthetic management of orthopedic surgery. This technique has lower complications rate,[@B27] including reduced blood loss[@B28] and decreased incidence of DVT.[@B29] It is possible that we might have obtained different outcomes if we had used intraoperative spinal anesthesia in this study. Moreover, in previous studies, the length of the hospital stay was shorter in patients who underwent TKA under spinal anesthesia compared with general anesthesia,[@B27] making spinal anesthesia more cost-effective.[@B30] In our study, there was no significant difference between the length of the hospital stay or the costs between the three groups because Japan\'s universal health insurance system keeps medical expenses relatively low for all patients, and patients tend to stay in the hospital until they complete their postoperative rehabilitation. Finally, all THAs in this study were performed through the Hardinge approach. It is not possible to perform CFNB using the anterior approach, including the direct anterior approach because of the skin incision adjacent to CFNB. Additionally, if studied in the patients undergoing THA *via* the posterolateral approach, dividing short rotators and quadratus femoris, a different outcome might be obtained.

Although there were no significant differences in postoperative HHS between the three groups in our study, postoperative CFNB use achieved good pain relief-equal to that of other analgesics-with fewer side effects in hospitalized patients following THA.
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![(A) VAS for each group at 24 hours postoperatively. The VAS scores were not significantly different among the three groups. (B) Additional analgesic treatment was given to each of the three groups for two days after surgery. Values are presented as mean ± standard deviation. VAS: visual analog scale, Epi: epidural analgesia, PCA: patient-controlled analgesia, CFNB: continuous femoral nerve block. ^\*^*p* \< 0.05.](cios-7-164-g001){#F1}

![Food intake of the three groups on postoperative day 1. Values are presented as mean ± standard deviation. Epi: epidural analgesia, PCA: patient-controlled analgesia, CFNB: continuous femoral nerve block. ^\*^*p* \< 0.05. ^\*\*^*p* \< 0.01.](cios-7-164-g002){#F2}

![D-dimer levels preoperatively (day 0) and on postoperative days 1, 3, and 7. Values are presented as mean ± standard deviation. Epi: epidural analgesia, PCA: patient-controlled analgesia, CFNB: continuous femoral nerve block. ^\*^*p* \< 0.05.](cios-7-164-g003){#F3}

###### Patient Background

![](cios-7-164-i001)

  ---------------------------------------------------------------------------------
  Variable                    Epi\          PCA\          CFNB\         *p*-value
                              (n = 30)      (n = 30)      (n = 30)      
  --------------------------- ------------- ------------- ------------- -----------
  Age (yr)                    64 ± 10.4     66.6 ± 12.7   68 ± 11.0     0.53

  Female                      23            26            26            0.63

  Body mass index (kg/m^2^)   23.4 ± 3.8    24.4 ± 4.1    23.4 ± 4.2    0.68

  Disease                                                               

   Osteoarthritis             25            27            25            

   Rheumatoid arthritis       1             1             1             

   ANFH                       3             1             3             

   Femoral neck fracture      1             1             1             

  Comorbidity index (point)   2.7 ± 1.7     3.0 ± 2.2     3.1 ± 1.0     0.64

  Harris hip score (point)    36.7 ± 13.3   37.8 ± 13.2   35 ± 19.0     0.37

  Operation time (min)        87.1 ± 22.0   87.8 ± 20.6   81.8 ± 18.6   0.53

  Bleeding (mL)               262 ± 147     233 ± 153     207 ± 127     0.42
  ---------------------------------------------------------------------------------

Values are presented as mean ± standard deviation.

Epi: epidural analgesia, PCA: patient-controlled analgesia, CFNB: continuous femoral nerve block, ANFH: avascular necrosis of the femoral head.
